These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29042316)

  • 21. Neurocognitive dysfunction following repeated binge-like self-administration of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).
    Sewalia K; Watterson LR; Hryciw A; Belloc A; Ortiz JB; Olive MF
    Neuropharmacology; 2018 May; 134(Pt A):36-45. PubMed ID: 29183686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of electroencephalogram (EEG) response to MDPV versus the hallucinogenic drugs MK-801 and ketamine in rats.
    Shokry IM; Sinha V; Da Silva G; Park SB; Callanan JJ; Tao R
    Exp Neurol; 2019 Mar; 313():26-36. PubMed ID: 30521789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discriminative Stimulus Effects of Binary Drug Mixtures: Studies with Cocaine, MDPV, and Caffeine.
    Collins GT; Abbott M; Galindo K; Rush EL; Rice KC; France CP
    J Pharmacol Exp Ther; 2016 Oct; 359(1):1-10. PubMed ID: 27493274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of acute and repeated methylenedioxypyrovalerone (MDPV) administration on striatal transcriptome networks in male long evans rats.
    Martyniuk CJ; Pompilus M; Schmidt J; Duncan A; Febo M
    Neurosci Lett; 2019 Nov; 712():134499. PubMed ID: 31536752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linear pharmacokinetics of 3,4-methylenedioxypyrovalerone (MDPV) and its metabolites in the rat: relationship to pharmacodynamic effects.
    Anizan S; Concheiro M; Lehner KR; Bukhari MO; Suzuki M; Rice KC; Baumann MH; Huestis MA
    Addict Biol; 2016 Mar; 21(2):339-47. PubMed ID: 25475011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).
    Watterson LR; Kufahl PR; Nemirovsky NE; Sewalia K; Grabenauer M; Thomas BF; Marusich JA; Wegner S; Olive MF
    Addict Biol; 2014 Mar; 19(2):165-74. PubMed ID: 22784198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The synthetic cathinone 3,4-methylenedioxypyrovalerone increases impulsive action in rats.
    Hyatt WS; Hirsh CE; Russell LN; Chitre NM; Murnane KS; Rice KC; Fantegrossi WE
    Behav Pharmacol; 2020 Jun; 31(4):309-321. PubMed ID: 32101987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exposure of adolescent mice to 3,4-methylenedioxypyrovalerone increases the psychostimulant, rewarding and reinforcing effects of cocaine in adulthood.
    López-Arnau R; Luján MA; Duart-Castells L; Pubill D; Camarasa J; Valverde O; Escubedo E
    Br J Pharmacol; 2017 May; 174(10):1161-1173. PubMed ID: 28262947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereoselective Actions of Methylenedioxypyrovalerone (MDPV) To Inhibit Dopamine and Norepinephrine Transporters and Facilitate Intracranial Self-Stimulation in Rats.
    Kolanos R; Partilla JS; Baumann MH; Hutsell BA; Banks ML; Negus SS; Glennon RA
    ACS Chem Neurosci; 2015 May; 6(5):771-7. PubMed ID: 25688761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular effects of 3,4-methylenedioxypyrovalerone (MDPV) in male and female Sprague-Dawley rats.
    McClenahan SJ; Hambuchen MD; Simecka CM; Gunnell MG; Berquist MD; Owens SM
    Drug Alcohol Depend; 2019 Feb; 195():140-147. PubMed ID: 30634109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the discriminative stimulus effects of 3,4-methylenedioxypyrovalerone in male Sprague-Dawley rats.
    Berquist MD; Baker LE
    Behav Pharmacol; 2017 Aug; 28(5):394-400. PubMed ID: 28598863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3,4-Methylenedioxypyrovalerone: Neuropharmacological Impact of a Designer Stimulant of Abuse on Monoamine Transporters.
    Magee CP; German CL; Siripathane YH; Curtis PS; Anderson DJ; Wilkins DG; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2020 Aug; 374(2):273-282. PubMed ID: 32385092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter.
    Cameron KN; Kolanos R; Solis E; Glennon RA; De Felice LJ
    Br J Pharmacol; 2013 Apr; 168(7):1750-7. PubMed ID: 23170765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of 3,4-methylenedioxypyrovalerone (MDPV) and 4-methylmethcathinone (mephedrone) in rats trained to discriminate MDMA or a d-amphetamine + MDMA mixture.
    Harvey EL; Baker LE
    Psychopharmacology (Berl); 2016 Feb; 233(4):673-80. PubMed ID: 26558618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-administration of the synthetic cathinones 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinopentiophenone (α-PVP) in rhesus monkeys.
    Collins GT; Sulima A; Rice KC; France CP
    Psychopharmacology (Berl); 2019 Dec; 236(12):3677-3685. PubMed ID: 31346629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is the 3,4-methylendioxypyrovalerone/mephedrone combination responsible for enhanced stimulant effects? A rat study with investigation of the effect/concentration relationships.
    Benturquia N; Chevillard L; Poiré C; Roussel O; Cohier C; Declèves X; Laplanche JL; Etheve-Quelquejeu M; Chen H; Mégarbane B
    Psychopharmacology (Berl); 2019 Mar; 236(3):891-901. PubMed ID: 29971461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs.
    Baumann MH; Bukhari MO; Lehner KR; Anizan S; Rice KC; Concheiro M; Huestis MA
    Curr Top Behav Neurosci; 2017; 32():93-117. PubMed ID: 27830575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Active vaccination reduces reinforcing effects of MDPV in male Sprague-Dawley rats trained to self-administer cocaine.
    McClenahan SJ; Gunnell MG; Owens SM; Fantegrossi WE
    Psychopharmacology (Berl); 2020 Sep; 237(9):2613-2620. PubMed ID: 32500210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Individual Differences in the Relative Reinforcing Effects of 3,4-Methylenedioxypyrovalerone under Fixed and Progressive Ratio Schedules of Reinforcement in Rats.
    Gannon BM; Galindo KI; Rice KC; Collins GT
    J Pharmacol Exp Ther; 2017 Apr; 361(1):181-189. PubMed ID: 28179474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of 3,4-methylenedioxypyrovalerone (MDPV) pre-exposure on the aversive effects of MDPV, cocaine and lithium chloride: Implications for abuse vulnerability.
    Woloshchuk CJ; Nelson KH; Rice KC; Riley AL
    Drug Alcohol Depend; 2016 Oct; 167():121-7. PubMed ID: 27520883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.